TMO
Price
$409.96
Change
-$4.79 (-1.15%)
Updated
Jul 21, 10:52 AM (EDT)
Capitalization
220.19B
2 days until earnings call
WAT
Price
$284.69
Change
-$2.61 (-0.91%)
Updated
Jul 21, 10:58 AM (EDT)
Capitalization
20.38B
14 days until earnings call
Interact to see
Advertisement

TMO vs WAT

Header iconTMO vs WAT Comparison
Open Charts TMO vs WATBanner chart's image
Thermo Fisher Scientific
Price$409.96
Change-$4.79 (-1.15%)
Volume$5.96K
Capitalization220.19B
Waters
Price$284.69
Change-$2.61 (-0.91%)
Volume$100
Capitalization20.38B
TMO vs WAT Comparison Chart in %
Loading...
TMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TMO vs. WAT commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TMO is a Hold and WAT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (TMO: $414.75 vs. WAT: $287.31)
Brand notoriety: TMO and WAT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: TMO: 104% vs. WAT: 114%
Market capitalization -- TMO: $220.19B vs. WAT: $20.38B
TMO [@Medical Specialties] is valued at $220.19B. WAT’s [@Medical Specialties] market capitalization is $20.38B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TMO’s FA Score shows that 0 FA rating(s) are green whileWAT’s FA Score has 1 green FA rating(s).

  • TMO’s FA Score: 0 green, 5 red.
  • WAT’s FA Score: 1 green, 4 red.
According to our system of comparison, WAT is a better buy in the long-term than TMO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TMO’s TA Score shows that 4 TA indicator(s) are bullish while WAT’s TA Score has 4 bullish TA indicator(s).

  • TMO’s TA Score: 4 bullish, 6 bearish.
  • WAT’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both TMO and WAT are a bad buy in the short-term.

Price Growth

TMO (@Medical Specialties) experienced а -4.62% price change this week, while WAT (@Medical Specialties) price change was -18.59% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.11%. For the same industry, the average monthly price growth was +2.74%, and the average quarterly price growth was -1.25%.

Reported Earning Dates

TMO is expected to report earnings on Jul 23, 2025.

WAT is expected to report earnings on Aug 04, 2025.

Industries' Descriptions

@Medical Specialties (-0.11% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TMO($220B) has a higher market cap than WAT($20.4B). TMO has higher P/E ratio than WAT: TMO (37.38) vs WAT (31.78). TMO YTD gains are higher at: -20.126 vs. WAT (-22.554). TMO has higher annual earnings (EBITDA): 11.1B vs. WAT (1B). TMO has more cash in the bank: 8.08B vs. WAT (396M). WAT has less debt than TMO: WAT (2.44B) vs TMO (34.9B). TMO has higher revenues than WAT: TMO (42.9B) vs WAT (2.96B).
TMOWATTMO / WAT
Capitalization220B20.4B1,078%
EBITDA11.1B1B1,109%
Gain YTD-20.126-22.55489%
P/E Ratio37.3831.78118%
Revenue42.9B2.96B1,451%
Total Cash8.08B396M2,040%
Total Debt34.9B2.44B1,429%
FUNDAMENTALS RATINGS
TMO vs WAT: Fundamental Ratings
TMO
WAT
OUTLOOK RATING
1..100
7260
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
87
Overvalued
PROFIT vs RISK RATING
1..100
7862
SMR RATING
1..100
5823
PRICE GROWTH RATING
1..100
6265
P/E GROWTH RATING
1..100
8570
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TMO's Valuation (54) in the Medical Specialties industry is somewhat better than the same rating for WAT (87). This means that TMO’s stock grew somewhat faster than WAT’s over the last 12 months.

WAT's Profit vs Risk Rating (62) in the Medical Specialties industry is in the same range as TMO (78). This means that WAT’s stock grew similarly to TMO’s over the last 12 months.

WAT's SMR Rating (23) in the Medical Specialties industry is somewhat better than the same rating for TMO (58). This means that WAT’s stock grew somewhat faster than TMO’s over the last 12 months.

TMO's Price Growth Rating (62) in the Medical Specialties industry is in the same range as WAT (65). This means that TMO’s stock grew similarly to WAT’s over the last 12 months.

WAT's P/E Growth Rating (70) in the Medical Specialties industry is in the same range as TMO (85). This means that WAT’s stock grew similarly to TMO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TMOWAT
RSI
ODDS (%)
Bearish Trend 11 days ago
55%
Bullish Trend 4 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
55%
Bullish Trend 4 days ago
64%
Momentum
ODDS (%)
Bearish Trend 4 days ago
52%
Bearish Trend 4 days ago
69%
MACD
ODDS (%)
Bearish Trend 4 days ago
52%
Bearish Trend 4 days ago
55%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
59%
Bearish Trend 4 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
61%
Bearish Trend 4 days ago
63%
Advances
ODDS (%)
Bullish Trend 11 days ago
60%
Bullish Trend 12 days ago
66%
Declines
ODDS (%)
Bearish Trend 6 days ago
63%
Bearish Trend 7 days ago
60%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
57%
Bullish Trend 4 days ago
72%
Aroon
ODDS (%)
Bullish Trend 4 days ago
64%
Bearish Trend 4 days ago
51%
View a ticker or compare two or three
Interact to see
Advertisement
TMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NOM11.000.26
+2.42%
Nuveen Missouri Quality Municipal Income Fund
RSPT41.570.19
+0.46%
Invesco S&P 500® Equal Weight Tech ETF
JLQD41.15N/A
-0.01%
Janus Henderson Corporate Bond ETF
SIXA48.62-0.02
-0.04%
ETC 6 Meridian Mega Cap Equity ETF
KF27.24-0.09
-0.35%
Korea Fund

TMO and

Correlation & Price change

A.I.dvisor indicates that over the last year, TMO has been closely correlated with DHR. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if TMO jumps, then DHR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TMO
1D Price
Change %
TMO100%
-2.41%
DHR - TMO
81%
Closely correlated
-2.43%
A - TMO
80%
Closely correlated
-2.04%
MTD - TMO
78%
Closely correlated
-0.90%
RVTY - TMO
76%
Closely correlated
-2.36%
BRKR - TMO
70%
Closely correlated
-3.89%
More

WAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, WAT has been closely correlated with A. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if WAT jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WAT
1D Price
Change %
WAT100%
-3.24%
A - WAT
79%
Closely correlated
-2.04%
MTD - WAT
73%
Closely correlated
-0.90%
RVTY - WAT
68%
Closely correlated
-2.36%
TMO - WAT
65%
Loosely correlated
-2.41%
BRKR - WAT
65%
Loosely correlated
-3.89%
More